Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors.
Evans M, Morgan AR, Yousef Z, Ellis G, Dashora U, Patel DC, Brown P, Hanif W, Townend JN, Kanumilli N, Moore J, Wilding JPH, Bain SC.
Evans M, et al.
Drugs. 2021 Jul;81(11):1243-1255. doi: 10.1007/s40265-021-01538-6. Epub 2021 Jun 23.
Drugs. 2021.
PMID: 34160822